7 Days in Science – September 27, 2019
List Sep 27, 2019
How Does Cancer Cause Muscle Wasting?
A research group at NTNU and several partners have identified a possible mechanism for how cancer cells may be sending messages to muscle cells resulting in cancer-related muscle wasting.
Published in: Journal of Cachexia
Senescent Cells May Play a Role in Thrombosis
Senescent cells may underlie clotting predisposition, suggest the findings from a recent study by researchers at the Buck Institute for Research on Aging.
Published in: Cell Reports
Imposter Syndrome Is More Common Than You Might Think
A new study into impostor syndrome, a phenomenon that manifests when people feel like frauds even if they are actually capable and well-qualified, reveals that perceptions of impostorism are more common than you might expect.
Published in: The Journal of Vocational Behavior
Therapy for Cancer Relapse Patients Could Be in Clinical Trials Within Six Months
A novel CAR T-Cell therapy that targets the BAFF-R protein, as opposed to CD19, could be in clinical trials within six months. The therapy may offer a new treatment avenue for blood cancer patients experiencing relapse.
Published in: Science Translational Medicine
Read full story
Study Explores Integrity of Research Specimens
Biological samples can be highly susceptible to changes over time, and degraded samples can produce spurious results in research. To address these concerns, scientists have designed a highly sensitive test that can be used to establish the integrity of blood plasma and serum, the most common biosamples used in medical research.
Published in: Molecular & Cellular Proteomics
Read full story
There has been an acceleration in our understanding of how cancer evades the immune system, and an explosion in new therapeutics that re-configure the immune system to mount a powerful anticancer response. Take a look at this list to find out more about the impact of aging on cancer development, how tumors evade the immune system and the current and future picture for “immunotherapy” cancer treatments.
Over recent years, the number of newly approved drugs brought to market has continued to decrease. Many drugs fail due to the fact they do not show efficacy at specific stages of the drug development pipeline, typically Phase II or Phase III. Subsequently, the pharmaceutical industry is facing pressures to optimize the drug discovery phase of the drug development pipeline, to avoid late-stage failures – one approach to doing this is by adopting automation. Find out how automation is impacting drug discovery in my latest infographic.
Cardiac Cells in the Shape of a Heart
Cardiac cells - which happen to be in the shape of a heart - on a hydrogel.
Credit: Brian Aguado
Like what you just read? You can find similar content on the communities below.Analysis & Separations Applied Sciences Biopharma Cancer Research Cell Science Diagnostics Drug Discovery Genomics Research Informatics Proteomics & Metabolomics Immunology & Microbiology
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE